Rockefeller Capital Management’s Benitec Biopharma BNTC Stock Holding History

Rockefeller Capital Management’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.2K	Buy	+582	New	+$6.74K	﹤0.01%	4183
2023 Q1	–	Sell	-18	Closed	–	–	2209
2022 Q4	$0	Hold	18	–	–	﹤0.01%	3864
2022 Q3	$0	Hold	18	–	–	﹤0.01%	3892
2022 Q2	$0	Hold	18	–	–	﹤0.01%	4104
2022 Q1	$0	Hold	18	–	–	﹤0.01%	3871
2021 Q4	$0	Hold	18	–	–	﹤0.01%	3774
2021 Q3	$1K	Hold	18	–	–	﹤0.01%	3539
2021 Q2	$1K	Hold	18	–	–	﹤0.01%	3310
2021 Q1	$1K	Hold	18	–	–	﹤0.01%	3156
2020 Q4	$0	Hold	18	–	–	﹤0.01%	2854
2020 Q3	$1K	Buy	+18	New	+$2.17K	﹤0.01%	2450

Other funds holding BNTC

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Rockefeller Capital Management's BNTC Position: Q1 2026 in Review

Rockefeller Capital Management opened a new position in Benitec Biopharma (BNTC) in Q1 2026: 582 shares worth $6.2K. The stake represents ﹤0.01% of the portfolio and ranks #4183 among its holdings. This is a return to the name: Rockefeller Capital Management previously reported a position in BNTC as recently as Q4 2022.

Rockefeller Capital Management first reported a position in BNTC in Q3 2020 and has held it in 11 quarters since. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

Rockefeller Capital Management held 582 shares of Benitec Biopharma worth $6.2K as of Q1 2026.
Benitec Biopharma was a new Rockefeller Capital Management position in Q1 2026.
Benitec Biopharma made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4183 holding.
Rockefeller Capital Management first reported a position in Benitec Biopharma in Q3 2020 and has held it in 11 quarters since.
88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.